NephroDI Therapeutics has signed a deal with the McQuade Center for Strategic Re...
Facilities in Andhra Pradesh and Telangana accounted for 23% of all sites in Ind...
The regulatory framework governing medicine development is in flux. CDMOs face g...
Erasca has obtained orphan drug designation (ODD) from the US FDA for ERAS-801 t...
Talaris Therapeutics has entered into a definitive agreement to merge with late-...
Kymera Therapeutics has announced that the FDA has granted KT-253 orphan drug de...
The medication could be a strong contender in the EU migraine market as a daily ...
"The world has failed to understand the social nature of diabetes and underestim...
The FDA rejected Intercept’s investigational treatment for NASH on Thursday, der...
The new rule doesn't explicitly make getting reimbursement easier, but it will a...
Lawmakers in both parties talked about overhauling a 2015 law, MACRA, that sets ...
In the latest edition of STAT's Health Tech newsletter: The best AI opportunitie...
This is not the final victory for people with Duchenne muscular dystrophy. It is...
The floodgates could open if the FDA approves Leqembi next month. Medicare just ...
Who's watching the drug price watchmen? Are RSV vaccines too expensive? And is i...
The Food and Drug Administration granted conditional approval Thursday to the fi...
